Saturday, March 29, 2025

Latest:

Gasdermin D emerges as a potential therapeutic target for atrial fibrillation
Healthy Habits: Dr. Sun In Kim-Vences is an ultramarathoner
Endometriosis and the lesser-known thoracic endometriosis syndrome
Postpartum female preference for cooler temperatures linked to brain changes
Baylor Genetics marks 10th anniversary: A look back at a decade of innovation in genetic testing

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Langerhans cell histiocytosis

A promising two-punch therapy for Langerhans cell histiocytosis

June 29, 2021 dendritic cells, Langerhans cell histiocytosis, MAPK inhibitor, PD-1 receptors, rare cancer, Research, T-cell exhaustion

A novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH.

From The Labs

The 2019 Michael E. DeBakey M.D. Awards for Excellence in Research

May 16, 2019 2019 DeBakey research awards, Batten disease, C. difficile, heart attack, Langerhans cell histiocytosis, lysosomal storage disorders, Neurodegeneration, NIH Roadmap Epigenomics, Research, trehalose, tropinin

The 2019 Michael E. DeBakey M.D. Award for Research Excellence ceremony honored five Baylor College of Medicine faculty members for their excellence in published scientific

From the Labs: Zika virus builds underground tunnels